ReP USP - Resultado da busca

Artigo de periodico
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice (2023)
Silva, Jamile Ramos da ; Rodrigues, Karine Bitencourt ; Pelegrin, Guilherme Formoso ; Sales, Natiely Silva ; Muramatsu, Hiromi ; Silva, Mariângela de Oliveira ; Porchia, Bruna Felício Milazzotto Maldonado ; Moreno, Ana Carolina Ramos ; Aps, Luana Raposo M. M. ; Carvalho, Aléxia Adrianne Venceslau ; Tombácz, István ; Fotoran, Wesley Luzetti ; Karikó, Katalin ; Lin, Paulo J. C.; Tam, Ying K. ; Diniz, Mariana de Oliveira ; Pardi, Norbert ; Ferreira, Luís Carlos de Souza
Source: Science Translational Medicine. Unidades: ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, VACINAS VIRAIS, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, PAPILLOMAVIRUS, HPV, INFECÇÕES POR PAPILLOMAVIRUS, NEOPLASIAS DO COLO UTERINO, PROTEÍNAS RECOMBINANTES, NANOPARTÍCULAS, NUCLEOSÍDEOS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jamile Ramos da et al. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Science Translational Medicine, v. 15, n. 686, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.abn3464. Acesso em: 02 jul. 2024.
APA
Silva, J. R. da, Rodrigues, K. B., Pelegrin, G. F., Sales, N. S., Muramatsu, H., Silva, M. de O., et al. (2023). Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Science Translational Medicine, 15( 686), 1-18. doi:10.1126/scitranslmed.abn3464
NLM
Silva JR da, Rodrigues KB, Pelegrin GF, Sales NS, Muramatsu H, Silva M de O, Porchia BFMM, Moreno ACR, Aps LRMM, Carvalho AAV, Tombácz I, Fotoran WL, Karikó K, Lin PJC, Tam YK, Diniz M de O, Pardi N, Ferreira LC de S. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice [Internet]. Science Translational Medicine. 2023 ; 15( 686): 1-18.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.abn3464
Vancouver
Silva JR da, Rodrigues KB, Pelegrin GF, Sales NS, Muramatsu H, Silva M de O, Porchia BFMM, Moreno ACR, Aps LRMM, Carvalho AAV, Tombácz I, Fotoran WL, Karikó K, Lin PJC, Tam YK, Diniz M de O, Pardi N, Ferreira LC de S. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice [Internet]. Science Translational Medicine. 2023 ; 15( 686): 1-18.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.abn3464
Artigo de periodico
CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice (2020)
Wang, Chih-Hao; Lundh, Morten; Fu, Accalia; Kriszt, Rókus; Huang, Tian Lian; Lynes, Matthew D.; Leiria, Luiz Osório Silveira ; Shamsi, Farnaz; Darcy, Justin; Greenwood, Bennett P.; Narain, Niven R.; Tolstikov, Vladimir; Smith, Kyle L.; Emanuelli, Brice; Chang, Young-Tae; Hagen, Susan; Danial, Nika N.; Kiebish, Michael A.; Tseng, Yu-Hua
Source: Science Translational Medicine. Unidade: FMRP
Subjects: TECIDO ADIPOSO, DIETA, OBESIDADE, TERMOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Chih-Hao et al. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Science Translational Medicine, v. 12, n. 558, 2020Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aaz8664. Acesso em: 02 jul. 2024.
APA
Wang, C. -H., Lundh, M., Fu, A., Kriszt, R., Huang, T. L., Lynes, M. D., et al. (2020). CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Science Translational Medicine, 12( 558). doi:10.1126/scitranslmed.aaz8664
NLM
Wang C-H, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LOS, Shamsi F, Darcy J, Greenwood BP, Narain NR, Tolstikov V, Smith KL, Emanuelli B, Chang Y-T, Hagen S, Danial NN, Kiebish MA, Tseng Y-H. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice [Internet]. Science Translational Medicine. 2020 ; 12( 558):[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aaz8664
Vancouver
Wang C-H, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LOS, Shamsi F, Darcy J, Greenwood BP, Narain NR, Tolstikov V, Smith KL, Emanuelli B, Chang Y-T, Hagen S, Danial NN, Kiebish MA, Tseng Y-H. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice [Internet]. Science Translational Medicine. 2020 ; 12( 558):[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aaz8664
Artigo de periodico
The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease (2015)
Sidman, Richard L; Li, Jianxue; Lawrence, Matthew; Hu, Wenzheng; Musso, Gary F; Giordano, Ricardo José ; Cardó-Vila, Marina; Pasqualini, Renata; Arap, Wadih
Source: Science Translational Medicine. Unidade: IQ
Subjects: DOENÇAS RETINIANAS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIDMAN, Richard L et al. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, v. 7, p. 1-15 art. 309, 2015Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aac4882. Acesso em: 02 jul. 2024.
APA
Sidman, R. L., Li, J., Lawrence, M., Hu, W., Musso, G. F., Giordano, R. J., et al. (2015). The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, 7, 1-15 art. 309. doi:10.1126/scitranslmed.aac4882
NLM
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882
Vancouver
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882
Artigo de periodico
A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice (2014)
Biressi, Stefano; Miyabara, Elen Haruka ; Gopinath, Suchitra D.; Carlig, Poppy M. M.; Rando, Thomas A.
Source: Science Translational Medicine. Unidade: ICB
Assunto: ANATOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIRESSI, Stefano et al. A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice. Science Translational Medicine, v. 6, n. 267, p. 1-12, 2014Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.3008411. Acesso em: 02 jul. 2024.
APA
Biressi, S., Miyabara, E. H., Gopinath, S. D., Carlig, P. M. M., & Rando, T. A. (2014). A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice. Science Translational Medicine, 6( 267), 1-12. doi:10.1126/scitranslmed.3008411
NLM
Biressi S, Miyabara EH, Gopinath SD, Carlig PMM, Rando TA. A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice [Internet]. Science Translational Medicine. 2014 ; 6( 267): 1-12.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3008411
Vancouver
Biressi S, Miyabara EH, Gopinath SD, Carlig PMM, Rando TA. A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice [Internet]. Science Translational Medicine. 2014 ; 6( 267): 1-12.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3008411
Artigo de periodico
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies (2014)
Bettegowda, Chetan; Sausen, Mark; Leary, Rebecca J.; Kinde, Isaac; Wang, Yuxuan; Agrawal, Nishant; Bartlett, Bjarne R.; Wang, Hao; Luber, Brandon; Alani, Rhoda M.; Antonarakis, Emmanuel S.; Azad, Nilofer S.; Bardelli, Alberto; Brem, Henry; Cameron, John L.; Lee, Clarence C.; Fecher, Leslie A.; Gallia, Gary L.; Gibbs, Peter; Le, Dung; Giuntoli, Robert L.; Goggins, Michael; Hogarty, Michael D.; Holdhoff, Matthias; Hong, Seung-Mo; Jiao, Yuchen; Juhl, Hartmut H.; Kim, Jenny J.; Siravegna, Giulia; Laheru, Daniel A.; Lauricella, Calogero; Lim, Michael; Lipson, Evan J.; Nagahashi Marie, Suely Kazue; Netto, George J.; Oliner, Kelly S.; Olivi, Alessandro; Olsson, Louise; Riggins, Gregory J.; Sartore-Bianchi, Andrea; Schmidt, Kerstin; Shih, le-Ming; Oba-Shinjo, Sueli Mieko; Siena, Salvatore; Theodorescu, Dan; Tie, Jeanne; Harkins, Timothy T.; Veronese, Silvio; Wang, Tian-Li; Weingart, Jon D.; Wolfgang, Christopher L.; Wood, Laura D.; Xing, Dongmei; Hruban, Ralph H.; Wu, Jian; Allen, Peter J.; Schmidt, C. Max; Choti, Michael A.; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas; Diaz Jr., Luis A.
Source: Science Translational Medicine. Unidade: FM
Subjects: DNA, BIOMARCADORES, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BETTEGOWDA, Chetan et al. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. Science Translational Medicine, v. 6, n. 224, p. 11 , 2014Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.3007094. Acesso em: 02 jul. 2024.
APA
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., et al. (2014). Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. Science Translational Medicine, 6( 224), 11 . doi:10.1126/scitranslmed.3007094
NLM
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong S-M, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Nagahashi Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih le-M, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang T-L, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz Jr. LA. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [Internet]. Science Translational Medicine. 2014 ; 6( 224): 11 .[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3007094
Vancouver
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong S-M, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Nagahashi Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih le-M, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang T-L, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz Jr. LA. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [Internet]. Science Translational Medicine. 2014 ; 6( 224): 11 .[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3007094
Artigo de periodico
Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers (2013)
Kinde, Isaac; Bettegowda, Chetan; Wang, Yuxuan; Wu, Jian; Agrawal, Nishant; Shih, Ie-Ming; Kurman, Robert; Dao, Fanny; Levine, Douglas A.; Giuntoli, Robert; Roden, Richard; Eshleman, James R.; Carvalho, Jesus Paula; Marie, Suely Kazue Nagahashi; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Diaz Jr., Luis A.
Source: Science Translational Medicine. Unidade: FM
Subjects: DNA (AVALIAÇÃO), GENÓTIPOS, NEOPLASIAS OVARIANAS, ENDOMÉTRIO (PATOLOGIA), NEOPLASIAS UTERINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KINDE, Isaac et al. Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers. Science Translational Medicine, v. 5, n. 167, p. 167ra4, 2013Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.3004952. Acesso em: 02 jul. 2024.
APA
Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, I. -M., et al. (2013). Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers. Science Translational Medicine, 5( 167), 167ra4. doi:10.1126/scitranslmed.3004952
NLM
Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, Shih I-M, Kurman R, Dao F, Levine DA, Giuntoli R, Roden R, Eshleman JR, Carvalho JP, Marie SKN, Papadopoulos N, Kinzler KW, Vogelstein B, Diaz Jr. LA. Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers [Internet]. Science Translational Medicine. 2013 ; 5( 167): 167ra4.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3004952
Vancouver
Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, Shih I-M, Kurman R, Dao F, Levine DA, Giuntoli R, Roden R, Eshleman JR, Carvalho JP, Marie SKN, Papadopoulos N, Kinzler KW, Vogelstein B, Diaz Jr. LA. Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers [Internet]. Science Translational Medicine. 2013 ; 5( 167): 167ra4.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3004952
Artigo de periodico
Challenges in Using Stem Cells for Cardiac Repair (2010)
Mummery, Christine L.; Davis, Richard P.; Krieger, José Eduardo
Source: Science Translational Medicine. Unidade: FM
Subjects: CÉLULAS-TRONCO (USO TERAPÊUTICO), PROCEDIMENTOS CIRÚRGICOS CARDÍACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUMMERY, Christine L. e DAVIS, Richard P. e KRIEGER, José Eduardo. Challenges in Using Stem Cells for Cardiac Repair. Science Translational Medicine, v. 2, n. 27, p. 27ps17, 2010Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.3000558. Acesso em: 02 jul. 2024.
APA
Mummery, C. L., Davis, R. P., & Krieger, J. E. (2010). Challenges in Using Stem Cells for Cardiac Repair. Science Translational Medicine, 2( 27), 27ps17. doi:10.1126/scitranslmed.3000558
NLM
Mummery CL, Davis RP, Krieger JE. Challenges in Using Stem Cells for Cardiac Repair [Internet]. Science Translational Medicine. 2010 ; 2( 27): 27ps17.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3000558
Vancouver
Mummery CL, Davis RP, Krieger JE. Challenges in Using Stem Cells for Cardiac Repair [Internet]. Science Translational Medicine. 2010 ; 2( 27): 27ps17.[citado 2024 jul. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3000558

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration